Phase 2 Trial of Interferon-Beta as Second-Line Treatment of Ovarian Cancer, Fallopian Tube Cancer, or Primary Carcinoma of the Peritoneum

Publisher： Karger

E-ISSN： 1423-0232|66|5|343-346

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.5, 2004-09, pp. : 343-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 1, 2015-07 ,pp. : 42-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)

By  

Oncology, Vol. 89, Iss. 2, 2015-03 ,pp. : 70-78

Karger

Access to resources Recommend Favorite

Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 238-246

Karger

Access to resources Recommend Favorite

Second-Line Treatment of Advanced Colorectal Cancer with a Weekly Simultaneous 24-Hour Infusion of 5-Fluorouracil and Sodium-Folinate: A Multicentre Phase II Trial

By  

Oncology Research and Treatment, Vol. 27, Iss. 5, 2004-10 ,pp. : 449-454

Karger

Access to resources Recommend Favorite